O'Shares富时美国优质红利ETF OUSA 深 沪
等待开盘 11-07 09:30:00 美东时间
55.5401
-0.421
-0.75%
华盛通- 最 高55.82
- 今 开55.76
- 成交量 2.20万股
- 最 低 55.495
- 昨 收 55.9614
- 总市值 8.37亿
- 52周最高 56.95
- 市盈率 静 --
- 换手率 0.15%
- 52周最低 46.7107
- 委 比 -13.61%
- 总股本 1507.50万
- 历史最高 56.95
- 量 比 1.06
- 振 幅 0.58%
- 历史最低 13.7217
- 每 手 1
- 风险率 1.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND
THOUSAND OAKS, Calif., Oct. 31, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the fourth quarter of 2025. The d...
11-01 04:01
Amgen To Present New Data From Cardiovascular Portfolio, Including Late-Breaking Results From Phase 3 VESALIUS-CV Clinical Trial Of Repatha, At AHASS 2025
Repatha VESALIUS-CV Trial Met Dual Primary Endpoints Demonstrating Reduction in CV Events in High-Risk Patients Who Have Never Had a Heart Attack or StrokeReal-World Evidence from the Repatha-CE Trial Reinforces Its
10-31 21:03
Amgen Announces FDA Approval Of TEZSPIRE For Chronic Rhinosinusitis With Nasal Polyps In Patients Aged 12 And Older, Expands Use To Second Epithelial-Driven Disease
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation
10-18 04:02
Amgen Announces The Phase 3 VESALIUS-CV Clinical Trial Met Its Dual Primary Endpoints Demonstrating That Repatha Significantly Reduced The Risk Of Major Adverse Cardiovascular Events In Individuals Without A Prior History Of Heart Attack Or Stroke
Adding Repatha to Standard Therapy of Statins or Other LDL-C Lowering Treatments Significantly Reduces Cardiovascular Events Compared with Standard Therapy AloneRepatha is Now the First and Only PCSK9 Inhibitor to
10-02 21:18
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS
THOUSAND OAKS, Calif., Sept. 26, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs. The plan...
09-26 21:00
Amgen To Invest Over $600M In New U.S. Science And Innovation Center, Creating Hundreds Of Jobs
Research and Development Infrastructure Investment Expected to Create Hundreds of U.S. Jobs THOUSAND OAKS, Calif., Sept. 2, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced plans to invest more than $600
09-02 21:04
AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE
THOUSAND OAKS, Calif., Aug. 29, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2025 Wells Fargo Healthcare Conference at 10:15 a.m. ET on Wednesday, Sept. 3, 2025. Paul Burton,...
08-30 04:01
AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND
THOUSAND OAKS, Calif., Aug. 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the third quarter of 2025. The div...
08-02 04:01
Catalyst Bancorp, Inc. Announces 2025 Second Quarter Results
OPELOUSAS, La., July 24, 2025 /PRNewswire/ -- Catalyst Bancorp, Inc. (Nasdaq: "CLST") (the "Company"), the parent company for Catalyst Bank (the "Bank") (www.catalystbank.com), reported net ...
07-24 19:00
漲超121% Opendoor成最新迷因股 成交額超車Meta
TradingKey - 美東時間週一（21日），房地產科技公司OpenDoor盤一度飆漲121%，最終收漲42%。由於波動劇烈，盤中一度被暫停交易。該股已連續第六個交易日上漲，六日漲幅高達312%，本月以來上漲502%。
07-22 11:36
